Patents expiring in 2036

US 9408829

Inhibitors of CD40-TRAF6 interaction

Ludwig-Maximilians-Universitat Munchen · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9408845

Formulations containing pyridazine compounds

Northwestern University · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9409662

Formulations of albu-BChE, preparation and uses thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9409965

Kidney-specific tumor vaccine directed against kidney tumor antigen G-250

The Regents of the University of California · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9409994

High-affinity monoclonal antibodies to glypican-3 and use thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9408813

Small-molecule inhibitors of dengue virus proteases

The Board of Regents of the University of Texas System · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9408844

Methods for treating inflammatory conditions

Melior Discovery, Inc. · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9408820

Broncholytic drug on the basis of prostaglandin

OBSCHESTVO S OGRANICHENNOY OTVETSTVENNOST'YU “NOXI LAB” · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9408896

Vaccination of companion animals to elicit a protective immune response against tick infestations and tick-borne pathogen transmission

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9408839

Antipsychotic treatment based on DRD2 or ANKK1 SNP genotype

VANDA PHARMACEUTICALS INC. · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9408901

Compositions, methods and uses for dengue virus serotype-4 constructs

The United States of America, as represented by the Secretary, Health and Human Services · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9409880

Modulators of TLR3/dsRNA complex and uses thereof

The Regents of the University of Colorado, a Body Corporate · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9409884

5- or 6-substituted benzofuran-2-carboxamide compounds and methods for using them

Rigel Pharmaceuticals, Inc. · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9409905

Antibacterial compounds and methods for use

PTC THERAPEUTICS, INC. · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9409934

Cyclohexenyl nucleic acids analogs

Ionis Pharmaceuticals, Inc. · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9409956

Salmonella typhi Ty21a expressing Yersinia pestis F1-V fusion protein and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9409963

Fibromodulin peptide

The Regents of the University of California · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9409990

Methods of inhibiting tumor growth by antagonizing IL-6 receptor

REGENERON PHARMACEUTICALS, INC. · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9409992

Mesothelin domain-specific monoclonal antibodies and use thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9410969

Method for determining and treating amyotrophic lateral sclerosis

China Medical University · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9410198

Compostions and methods of nucleic acid-targeting nucleic acids

Caribou Biosciences, Inc. · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9410913

Methods and systems for measuring and using the oxidation-reduction potential of a biological sample

Aytu BioScience, Inc. · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9410154

HBV treatment

Benitec Biopharma Limited · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9409972

Pharmaceutical composition and method of preparing same

SAISEI MIRAI CLINIC · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 3053920

VERBINDUNGEN MIT ANTITUMORAKTIVITÄT

AB SCIENCE [FR] · Granted Wed Aug 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Aug 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2016228376

MONOMETHYLFUMARATE PRODRUG COMPOSITIONS

ALKERMES PHARMA IRELAND LTD [IE] · Granted Thu Aug 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Aug 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9416361

Splice-region antisense composition and method

Sarepta Therapeutics, Inc. · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9415008

Dry powder inhaler

Teva Branded Pharmaceutical Products R&D, Inc. · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9416190

Mesothelin antibodies and methods for eliciting potent antitumor activity

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9416165

Methods of inhibiting viral replication and improving T cell function employing soluble Tim-3 inhibitors

The Regents of the University of California · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9415116

Compositions and methods for delivering inhibitory oligonucleotides

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9415109

Stable non-aggregating nucleic acid lipid particle formulations

Alnylam Pharmaceuticals, Inc. · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9415098

DNA vaccine for use in pancreatic cancer patients

Vaximm AG · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9414599

Process for the preparation of a metal complex in an oily organic matrix

Volare & Connecting, LLC · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9415004

Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

Rani Therapeutics, LLC · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9415006

Immunogenic compositions comprising nanoemulsion and hepatitis B virus immunogen and methods of using the same

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9415023

Compositions comprising terpene compounds for treating negative sensory phenomena

Board Of Supervisors Of Louisana State University And Agricultural And Mechanical College Pennington Biomedical Research Center · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9415041

Crystalline freebase forms of a biphenyl compound

Theravance Biopharma R&D IP, LLC · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9415040

Inhibition of quorum sensing-mediated processes in bacteria

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9415068

Method for inhibiting dentinal hypersensitivity

KURARAY NORITAKE DENTAL INC. · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9415087

Compositions and methods for treating coronavirus infection

Ludwig-Maximilians-Universitat Munchen · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9415105

Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9415099

Method of altering the immundominance hierarchy of HIV gag by DNA vaccine expressing conserved regions

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9415110

Method and compositions for targeted drug delivery to the lower GI tract

Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9415135

Methods and compositions for stabilizing the myocardium

The Regents of the University of California · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9416112

2,4-pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9416162

Peptides having reduced toxicity that stimulate cholesterol efflux

The Regents of the University of California · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9415123

Polymeric nanoparticles for ultrasound imaging and therapy

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)